ES2171676T3 - Inmunoensayos por quimioluminiscencia para la deteccion de anticuerpos. - Google Patents

Inmunoensayos por quimioluminiscencia para la deteccion de anticuerpos.

Info

Publication number
ES2171676T3
ES2171676T3 ES96916427T ES96916427T ES2171676T3 ES 2171676 T3 ES2171676 T3 ES 2171676T3 ES 96916427 T ES96916427 T ES 96916427T ES 96916427 T ES96916427 T ES 96916427T ES 2171676 T3 ES2171676 T3 ES 2171676T3
Authority
ES
Spain
Prior art keywords
chemoluminiscence
antibodies
detection
immuno tests
immuno
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96916427T
Other languages
English (en)
Inventor
Dinesh O Shah
Russell B Richardson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23674735&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2171676(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of ES2171676T3 publication Critical patent/ES2171676T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/805—Optical property
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Peptides Or Proteins (AREA)

Abstract

UN ENSAYO QUIMIOLUMINISCENTE QUE UTILIZA UN PRECOMPLEJO REACTIVO DE UNA SONDA QUE COMPRENDE UN COMPUESTO ESTIMULADOR, COMO UN HAPTENO Y UN CONJUGADO QUE COMPRENDE UN COMPUESTO QUE GENERA UNA SEÑAL QUIMIOLUMINISCENTE. TAMBIEN SE PROPORCIONAN KITS PARA LA REALIZACION DE UN ENSAYO QUIMIOLUMINISCENTE.
ES96916427T 1995-04-14 1996-04-09 Inmunoensayos por quimioluminiscencia para la deteccion de anticuerpos. Expired - Lifetime ES2171676T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/422,404 US5705330A (en) 1995-04-14 1995-04-14 Chemiluminescent immunoassay for antibody detection

Publications (1)

Publication Number Publication Date
ES2171676T3 true ES2171676T3 (es) 2002-09-16

Family

ID=23674735

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96916427T Expired - Lifetime ES2171676T3 (es) 1995-04-14 1996-04-09 Inmunoensayos por quimioluminiscencia para la deteccion de anticuerpos.

Country Status (8)

Country Link
US (1) US5705330A (es)
EP (1) EP0820597B1 (es)
JP (1) JP3611579B2 (es)
AT (1) ATE212130T1 (es)
CA (1) CA2217818C (es)
DE (1) DE69618580T2 (es)
ES (1) ES2171676T3 (es)
WO (1) WO1996032004A2 (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3715027B2 (ja) * 1996-05-07 2005-11-09 シスメックス株式会社 Ｃ型肝炎ウイルス感染症診断薬
PT1021719E (pt) 1997-09-22 2007-03-30 Novartis Vaccines & Diagnostic Método para detecção de anticorpos numa amostra
WO1999015901A1 (en) * 1997-09-22 1999-04-01 Chiron Corporation Buffers for stabilizing antigens
CZ298268B6 (cs) * 1998-04-17 2007-08-08 Innogenetics N. V. Imunodiagnostický test používající redukující cinidla
GB2339018B (en) 1998-06-22 2003-07-30 Ortho Clinical Diagnostics Specific binding assays using methyl orange
US6203974B1 (en) * 1998-09-03 2001-03-20 Abbott Laboratories Chemiluminescent immunoassay for detection of antibodies to various viruses
WO2001063299A1 (en) * 2000-02-23 2001-08-30 Besst-Test Aps METHOD FOR CORRELATING BLOOD COAGULATION ACTIVITY WITH MARKERS IN BODY FLUIDS, e.g. URINE
AU2001265419B2 (en) * 2000-06-02 2007-03-01 Cytometry Applications, Inc. No wash bead assay, kit and procedure
JP4353793B2 (ja) * 2001-06-26 2009-10-28 アボット・ラボラトリーズ Ｈｃｖ抗原とｈｃｖ抗体との同時検出のための方法
US7101683B2 (en) 2001-06-26 2006-09-05 Abbott Laboratories Methods for the simultaneous detection of HCV antigens and HCV antibodies
US6723851B2 (en) 2001-10-31 2004-04-20 Quest Diagnostics Investment Incorporated Chemiluminescent compounds and use thereof
US20030232386A1 (en) * 2002-06-17 2003-12-18 Shah Dinesh O. Assay conjugate and uses thereof
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
US20040152070A1 (en) * 2003-02-04 2004-08-05 Shah Dinesh O. Method of detection of HCV antibodies in combination assay or sole antibody assay
MX2007010687A (es) 2005-03-05 2008-01-28 Abbott Gmbh & Co Kg Metodo de clasificacion, procedimiento para la purificacion de oligomeros a-beta no difundibles, anticuerpos selectivos contra dichos oligomeros a-beta no difundibles y un procedimiento para la fabricacion de dichos anticuerpos.
US7432046B2 (en) * 2005-11-02 2008-10-07 Abbott Laboratories Methods for the determination of antibody IgG avidity
PT1976877E (pt) * 2005-11-30 2014-04-29 Abbvie Inc Anticorpos monoclonais contra proteína beta-amilóide e suas utilizações
BRPI0619249A2 (pt) 2005-11-30 2011-09-20 Abbott Lab anticorpos anti-globulÈmeros-aß, frações que se ligam a antìgeno destes, hibridomas correspondentes, ácidos nucléicos, vetores, células hospedeiras, métodos de produzir os ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos de usar os ditos anticorpos
US20080220448A1 (en) * 2006-09-01 2008-09-11 Blincko Stuart J Antigenic protein conjugates and process for preparing same
US8865398B2 (en) 2006-09-01 2014-10-21 Abbott Laboratories Combination hepatitis C virus antigen and antibody detection method
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
EP2124952A2 (en) * 2007-02-27 2009-12-02 Abbott GmbH & Co. KG Method for the treatment of amyloidoses
WO2009005968A1 (en) * 2007-07-03 2009-01-08 Scantibodies Laboratory, Inc. Assays for detecting antibodies to therapeutics
US20090053736A1 (en) * 2007-08-21 2009-02-26 Mattingly Phillip G Homogeneous Chemiluminescent Immunoassay for Analysis of Iron Metalloproteins
US20090068635A1 (en) * 2007-09-06 2009-03-12 Muerhoff Anthony S Indirectly labelled assay conjugates and methods of preparing and using same
US20090148879A1 (en) * 2007-12-10 2009-06-11 Mattingly Phillip G Stabilizing Compositions, Methods and Kits for Chemiluminescent Assays
US8030471B2 (en) * 2008-03-06 2011-10-04 Abbott Laboratories Plasmodium malariae and Plasmodium ovale genes and uses thereof
US8268981B2 (en) 2008-03-06 2012-09-18 Abbott Laboratories Plasmodium malariae and plasmodium ovale genes and uses thereof
WO2010010469A2 (en) * 2008-07-25 2010-01-28 Abbott Gmbh & Co. Kg Abeta (x-38..43) oligomers, and processes, compositions, and uses thereof
US8030026B2 (en) 2009-02-24 2011-10-04 Abbott Laboratories Antibodies to troponin I and methods of use thereof
US8283162B2 (en) 2009-03-10 2012-10-09 Abbott Laboratories Antibodies relating to PIVKAII and uses thereof
AU2009342630B2 (en) 2009-03-18 2015-09-03 Nestec S.A. Addressable antibody arrays and methods of use
US8063193B2 (en) 2009-03-27 2011-11-22 Abbott Laboratories Nucleotide and amino acid sequences encoding an exported protein 1 derived from Plasmodium vivax and uses thereof
US20110004085A1 (en) 2009-04-30 2011-01-06 Dexcom, Inc. Performance reports associated with continuous sensor data from multiple analysis time periods
EP2558494B1 (en) 2010-04-15 2018-05-23 AbbVie Inc. Amyloid-beta binding proteins
US9551714B2 (en) * 2010-06-25 2017-01-24 Abbott Laboratories Materials and methods for assay of anti-hepatitis C virus (HCV) antibodies
US9120862B2 (en) 2010-07-26 2015-09-01 Abbott Laboratories Antibodies relating to PIVKA-II and uses thereof
CN105348387B (zh) 2010-08-14 2020-08-25 Abbvie 公司 β淀粉样蛋白结合蛋白
CN105378099B (zh) 2013-03-14 2021-05-11 雅培制药有限公司 Hcv核心脂质结合结构域单克隆抗体
EP2970947A4 (en) 2013-03-14 2016-10-12 Abbott Lab RECOMBINANT HCV NS3 ANTIGENS AND THEIR MUTANTS FOR ENHANCED ANTIBODY DETECTION
JP6505076B2 (ja) 2013-03-14 2019-04-24 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ Ｈｃｖ抗原−抗体組み合わせアッセイおよびこれに使用するための方法および組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4228237A (en) * 1978-09-21 1980-10-14 Calbiochem-Behring Corp. Methods for the detection and determination of ligands
US4469787A (en) * 1982-05-14 1984-09-04 Mallinckrodt Inc. Immunoassay involving soluble complex of second antibody and labeled binding protein
IL75020A (en) * 1984-05-10 1988-10-31 Abbott Lab Biotin-antibiotin immunoassay for the detection of ligands
US4935339A (en) * 1985-05-07 1990-06-19 Nichols Institute Diagnostics Delayed solid phase immunologic assay
US4959182A (en) * 1986-07-17 1990-09-25 Board Of Governors Of Wayne State University Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes
US4927769A (en) * 1987-07-08 1990-05-22 Ciba Corning Diagnostics Corp. Method for enhancement of chemiluminescence
JPH06501559A (ja) * 1990-11-09 1994-02-17 アボット・ラボラトリーズ 増幅不均一化学ルミネッセンスイムノアッセイ

Also Published As

Publication number Publication date
WO1996032004A2 (en) 1996-10-17
CA2217818C (en) 2010-10-26
DE69618580T2 (de) 2002-09-26
WO1996032004A3 (en) 1996-11-14
JPH11503829A (ja) 1999-03-30
EP0820597A2 (en) 1998-01-28
CA2217818A1 (en) 1996-10-17
US5705330A (en) 1998-01-06
DE69618580D1 (de) 2002-02-21
EP0820597B1 (en) 2002-01-16
ATE212130T1 (de) 2002-02-15
JP3611579B2 (ja) 2005-01-19

Similar Documents

Publication Publication Date Title
ATE212130T1 (de) Chemilumineszenz-immunoassay für den antikörpernachweis
PT97580A (pt) Sondas de proteina-acido nucleico e imunoensaios que utilizam as mesmas
DE69407402D1 (de) Repamycinbestimmung
ES2148225T3 (es) Reactivos y procedimientos que permiten la deteccion y la cuantificacion de la tiroxina en muestras de fluido.
DE69731977D1 (de) Spezifische antikörper für dendritische zellen
CY1107621T1 (el) Μεθοδος ανιχνευσης αντισωματων σε ενα δειγμα
ES512498A0 (es) "metodo y su correspondiente aparato para el ensayo de anticuerpos con respecto a antigenos solubles".
WO2003046140A3 (en) Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample
ES2184803T3 (es) Procedimiento para la realizacion de un ensayo inmunologico en un sistema multifasico.
NO163920C (no) Fremgangsmaate for bestemmelse av pivka-ii i fysiologiske proever.
PT902286E (pt) Imunoensaio utilizando duas incubacoes com antigenios marcados
ATE240522T1 (de) Chemilumineszenz-immunoassay zum nachweis eines mit der chagas-erkränkung verbundenen analyts in einer probe
BR9609390A (pt) Ensaio quimiluminescente de ligação específica com não-separação
KR930702680A (ko) 증폭된 불균질 화학발광 면역 검정법
DE69921987D1 (de) IMMUNTEST FÜR HUMAN CHROMOGRANINE A (CgA), ANTIKÖRPER, REAGENZ UND DAZU GEEIGNETER TESTSATZ
ES522722A1 (es) Procedimiento de inmunoanalisis para determinar propanolol en una muestra
ES2176229T3 (es) Compuestos quimioluminiscentes de longitud de onda de emision larga y su uso en ensayos de prueba.
ES2019573T3 (es) Inmunoensayo para la deteccion de alfa-haloacetamidas.
ATE278193T1 (de) Verfahren zum testen eines asialoglycoproteinrezeptors und testreagenz dafür
ATE285075T1 (de) Detektion und quantifikation von vancomycin in den biologischen flüssigkeiten
ES2168378T3 (es) Determinacion de tripsinogeno-2 libre y en forma de complejo.
SE9303272D0 (sv) Improvement in immunoassays
ATE260936T1 (de) 5-hydroxytryptophol (5-htol) derivate, antikörper,immunoassays und detektion von kürzfristigem alkoholkonsum
AR002242A1 (es) Haptenos de imidazolinona y antigenos y conjugados enzimáticos preparados a partir de los mismos, compuestos intermediarios para preparar los haptenos, anticuerpos, hibridomas, y ,usos de los haptenos e hibridomas
HU9701386D0 (en) Immunoassay method

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 820597

Country of ref document: ES